Filing Flows › GSK (GSK) › Q3 2026 › vs Q2 2026
GSK (GSK) Q3 2026 vs Q2 2026 (quarter over quarter)
GSK's revenue rose $138M (+2%) from $8.4B in Q2 2026 to $8.5B in Q3 2026. Gross margin 73.6% against 73.1% (+0.5 pts).
GSK, Q3 2026: revenue $8.5B, operating margin 30.3%, net earnings $2.0B. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 73.6% | 73.1% | +0.5 pts |
| Operating margin | 30.3% | 5.7% | +24.6 pts |
| Net margin | 23.6% | 5.2% | +18.4 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $8.5B | $8.4B | $138M | +2% |
| Gross profit | $6.3B | $6.1B | $146M | +2% |
| Cost of revenue | $2.3B | $2.3B | −$8.0M | -0.4% |
| Operating profit | $2.6B | $481M | $2.1B | +439% |
| Operating expenses | $3.7B | $5.7B | −$2.0B | -35% |
| Pre-tax earnings | $2.5B | $354M | $2.1B | +594% |
| Other expense, net | $137M | $127M | $10.0M | +8% |
| Research & development | $1.7B | $3.5B | −$1.8B | -51% |
| Other operating costs | $2.0B | $2.2B | −$189M | -9% |
| Net earnings | $2.0B | $435M | $1.6B | +363% |
| Minority interests | $131M | $118M | $13.0M | +11% |
| Income tax | $312M | −$199M | $511M | — |
Questions
How much did GSK's revenue grow quarter over quarter in Q3 2026?
GSK's revenue rose $138M (+2%) from $8.4B in Q2 2026 to $8.5B in Q3 2026. Gross margin 73.6% against 73.1% (+0.5 pts).